Kaye SB - Search Results

1

Bilateral testicular cancer: a preventable problem? Experience from a large cancer centre.

Pamenter B, De Bono JS, Brown IL, Nandini M, Kaye SB, Russell JM, Yates AJ, Kirk D. Pamenter B, et al. Among authors: kaye sb. BJU Int. 2003 Jul;92(1):43-6. doi: 10.1046/j.1464-410x.2003.04285.x. BJU Int. 2003. PMID: 12823381

2

Improved prognosis of patients with intermediate- and poor-risk nonseminomatous germ cell tumours by optimizing combined treatment.

Pentheroudakis G, De Bono JS, Kaye SB, Simpson A, Paul J, Brown I, Pamenter B, Kirk A, Vasey P, Raby N, Kirk D. Pentheroudakis G, et al. Among authors: kaye sb. BJU Int. 2003 Jul;92(1):36-42. doi: 10.1046/j.1464-410x.2003.04261.x. BJU Int. 2003. PMID: 12823380

3

Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumours.

Harding MJ, Brown IL, MacPherson SG, Turner MA, Kaye SB. Harding MJ, et al. Among authors: kaye sb. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1689-94. doi: 10.1016/0277-5379(89)90336-2. Eur J Cancer Clin Oncol. 1989. PMID: 2561098

4

Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).

de Bono JS, Paul J, Simpson A, Anthoney A, Kirk D, Underwood M, Graham J, Kaye SB. de Bono JS, et al. Among authors: kaye sb. Br J Cancer. 2000 Aug;83(4):426-30. doi: 10.1054/bjoc.2000.1290. Br J Cancer. 2000. PMID: 10945485 Free PMC article.

5

The changing role of surgery in metastatic non-seminomatous germ cell tumour.

Cassidy J, Lewis CR, Kaye SB, Kirk D. Cassidy J, et al. Among authors: kaye sb. Br J Cancer. 1992 Jan;65(1):127-9. doi: 10.1038/bjc.1992.24. Br J Cancer. 1992. PMID: 1370759 Free PMC article.

6

Retroperitoneal surgery: its wider role in the management of malignant teratoma.

Hollins GW, Thomas S, Lanigan DJ, Dahar N, Jodrell D, Kaye SB, Kirk D. Hollins GW, et al. Among authors: kaye sb. Br J Urol. 1996 Apr;77(4):571-6. doi: 10.1046/j.1464-410x.1996.93116.x. Br J Urol. 1996. PMID: 8777620

7

Low dose methotrexate and doxorubicin in hormone-resistant prostatic cancer. Scottish Urological Oncology Group.

Smith MF, Lawson AH, Kirk D, Kaye SB. Smith MF, et al. Among authors: kaye sb. Br J Urol. 1990 May;65(5):513-6. doi: 10.1111/j.1464-410x.1990.tb14798.x. Br J Urol. 1990. PMID: 2354318

8

A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit.

Brunetto AT, Sarker D, Papadatos-Pastos D, Fehrmann R, Kaye SB, Johnston S, Allen M, De Bono JS, Swanton C. Brunetto AT, et al. Among authors: kaye sb. Br J Cancer. 2010 Aug 24;103(5):607-12. doi: 10.1038/sj.bjc.6605812. Epub 2010 Jul 27. Br J Cancer. 2010. PMID: 20664586 Free PMC article.

9

Reversing resistance to targeted therapy.

Vidal L, Attard G, Kaye S, De Bono J. Vidal L, et al. J Chemother. 2004 Nov;16 Suppl 4:7-12. doi: 10.1179/joc.2004.16.Supplement-1.7. J Chemother. 2004. PMID: 15688600 Review.

10

Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experience.

Molife LR, Alam S, Olmos D, Puglisi M, Shah K, Fehrmann R, Trani L, Tjokrowidjaja A, de Bono JS, Banerji U, Kaye SB. Molife LR, et al. Among authors: kaye sb. Ann Oncol. 2012 Aug;23(8):1968-1973. doi: 10.1093/annonc/mds030. Epub 2012 Mar 9. Ann Oncol. 2012. PMID: 22408187 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

739 results

Search Page

Filters